IP Library Granted Patent US 9,121,851
Granted Patent B2
US 9,121,851 · App. 13/893,258 · Granted Sep 1, 2015

Modular point-of-care devices, systems, and uses thereof

Inventors: Tammy Burd (San Jose, CA); Ian Gibbons (Portola Valley, CA); Elizabeth A. Holmes (Palo Alto, CA); Gary Frenzel (Mountain View, CA); Anthony Joseph Nugent (Dublin, CA)
Assignee: Theranos, Inc.
G01N33/56966B01J19/0046B01L3/5025G01N1/38G01N33/5302G01N33/54386G01N35/028B01J2219/005B01J2219/00283B01J2219/00292B01J2219/00315B01J2219/00369B01J2219/00371B01J2219/00385B01J2219/00466B01J2219/00495B01J2219/00693B01J2219/00702B01L3/021B01L3/0262B01L3/527B01L7/5255B01L2200/04B01L2200/0689B01L2200/141B01L2200/148B01L2300/0654B01L2300/0829B01L2300/1805B01L2400/043G01N2035/0097G01N2333/71Y10T29/49826Y10T436/25375
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,121,851
App. No.
13/893,258
Granted
Sep 1, 2015
Kind
B2
Abstract

The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.

Claims (39)

1. A system for detection of a first analyte and a second analyte in a biological sample, comprising:

i) cartridge comprising a housing carrying a plurality of movable assay units configured to run chemical reactions on portions of said biological sample, wherein said chemical reactions are configured to yield detectable signals indicative of the presence or absence of said first analyte and said second analyte in the biological sample, wherein said housing is configured to carry a plurality of reagent units;

ii) a plurality of movable reagent units separate from said housing, said reagent units being filled with reagents for running said chemical reactions, wherein individual reagent units are calibrated with reference to corresponding assay units;

iii) a pipette assembly configured to transport aliquots of fluid and to transport assay units, said pipette assembly comprising pipette heads configured to engage said assay units; and

iv) a detection assembly for detecting said signals indicative of the presence or absence of said first and second analytes in the biological sample.

2. The system of claim 1 , wherein said analytes are selected from the group of analyte types consisting of protein analytes, nucleic acid analytes, organic analytes, and inorganic analytes.

3. The system of claim 1 further comprising a sample collection unit configured to receive a biological sample, wherein said fluidic device a) is configured to engage said sample collection unit, or b) comprises said sample collection unit.

4. The system of claim 1 , further comprising a reader assembly configured to engage said fluidic device.

5. The system of claim 1 , comprising an assay unit configured to be moved into fluid communication with a reagent unit.

6. The system of claim 1 , wherein said pipette assembly is configured to transfer a reagent effective to dilute at least a portion of a biological sample, to mix at least a portion of a biological sample with a reagent, to react with at least a portion of a biological sample with a reagent, or combinations thereof.

7. The system of claim 1 , wherein said detection assembly comprises an optical detector.

8. The system of claim 7 , wherein said optical detector comprises a photodiode, an avalanche photodiode, a photomultiplier (PMT), a photon counting detector, a charge-coupled device, or a pin diode.

9. The system of claim 1 , wherein said detection assembly comprises a plurality of detectors.

10. The system of claim 1 , wherein said detection assembly is configured to detect a signal from a nucleic acid assay, a signal from an immunoassay, or both.

11. The system of claim 1 , wherein said system comprises a system selected from one or more of: a point of care system for detecting analytes in a biological sample; a portable system for detecting analytes in a biological sample; a desk-top system for detecting analytes in a biological sample; and a bench-top system for detecting analytes in a biological sample.

12. The system of claim 1 , wherein said biological sample is selected from the group consisting of blood, serum, plasma, saliva, urine, tears, gastric fluid, digestive fluid, bone marrow, cerebrospinal fluid, stool, semen, vaginal fluid, and liquid extracted from tissue.

13. The system of claim 1 , wherein said biological sample has a volume selected from the group of volumes consisting of: less than about 500 microliters (μL); about 1 μL to 100 μL; about 1 μL to 50 μL; about 1 μL to 40 μL; about 1 μL to 30 μL; about 1 μL to 10 μL; and about 1 μL to 3 μL.

14. The system of claim 1 , wherein said pipette assembly is configured to transport at least a portion of a biological sample to said detection assembly.

15. The system of claim 1 , further comprising a pretreatment unit configured to separate, dilute, process, or retrieve a portion of said biological sample, or combinations thereof.

16. The system of claim 1 , wherein said pipette assembly comprises an air-displacement pipette.

17. The system of claim 1 , comprising a pipette head comprising a nozzle.

18. The system of claim 17 , wherein said nozzle is configured to engage a pipette tip.

19. The system of claim 1 , wherein the pipette assembly is configured to operate according to a protocol.

20. The system of claim 19 , wherein said protocol is configured to be adjustable without requiring modification of the system.

21. The system of claim 1 , wherein the pipette assembly is configured for automated operation.

22. The system of claim 1 , further comprising a communication assembly, wherein said communication assembly is configured to transmit information, to receive information, or both.

23. The system of claim 22 , wherein operation of said system comprises operation according to a protocol, wherein said protocol is configured to incorporate information received by said communication assembly.

24. The system of claim 23 , wherein said protocol is configured to be adjustable without requiring modification of the system.

25. The system of claim 1 , wherein said detection assembly comprises a detectable range, and wherein said pipette assembly is configured to effect a degree of dilution of the biological sample in the array of assay units effective to bring signals indicative of at least two analytes in said biological sample within a detectable range, effective that said at least two analytes are detectable with said system.

26. The system of claim 1 , comprising an assay unit comprising an assay tip that is configured to receive a portion of the sample and a reagent.

27. The system of claim 1 , comprising assay units and reagent units configured to perform at least two assays in parallel.

28. The system of claim 1 , comprising an assay unit and a reagent unit configured to move relative to each other effective that a reagent for running a chemical reaction is brought into contact with at least a portion of the biological sample in the assay unit.

29. The system of claim 1 , wherein said fluidic device comprises a calibration unit.

30. The system of claim 1 , wherein said biological sample has a volume selected from the group of volumes of about 1 microliters (μL) to 50 μL and about 1 μL to 10 μL.

31. A system for detection of a first analyte and a second analyte in a biological sample, comprising:

i) cartridge comprising a housing carrying an array of addressable assay units configured to run chemical reactions on portions of said biological sample, wherein said chemical reactions are configured to yield detectable signals indicative of the presence or absence of said first analyte and said second analyte in the biological sample, wherein said housing is configured to carry a plurality of reagent units;

ii) a plurality of reagent units separate from said housing, said reagent units being filled with reagents for running said chemical reactions, wherein individual reagent units are calibrated with reference to corresponding individual addressable assay units, and individual reagent units are addressed to correspond to individual addressable assay units;

iii) a pipette assembly configured to transport aliquots of fluid and to transport assay units, said pipette assembly comprising pipette heads configured to engage said assay units; and

iv) a detection assembly for detecting said signals indicative of the presence or absence of said first and second analytes in the biological sample.

Assignments (5)
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045101/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2015
From: BURD, TAMMY; GIBBONS, IAN; HOLMES, ELIZABETH A.; FRENZEL, GARY; NUGENT, ANTHONY J.
To: THERANOS, INC.
Reel/Frame 035560/0406 →
Continuity (5)
Continuation 13889674 · May 8, 2013
Continuation 13326023 · Dec 14, 2011
Continuation 12244723 · Oct 2, 2008
Provisional Application 60997460 · Oct 2, 2007
Related Publication 20130252320A1 · Sep 26, 2013